Using Procurement to Drive Value in Today’s Fluctuating Pharma Industry

Join Elizabeth Robillard, program director for ProcureCon Pharma, as she kicks off the first day of the event!

---

Join program director Elizabeth Robillard as she leads attendees through a short getting to know you ice breaker consisting of a Philly fun facts trivia game.

---

Given the sensitive nature of clinical trials, the way they are purchased and the agreements involved can be cumbersome and complicated. Dave Freschi and Ratan Ratnesh will walk us through best practices involved with sourcing this expensive category specifically. They will talk about things like:

-Ranking and evaluating key outsourcing variables — the money, the contract and the people
-Understanding the perspective of legal, compliance and R&D before conducting research on perspective suppliers and analyze criteria and considerations for vetting CMOs
-Reviewing potential vendors, requesting proposals (what info should be included)
-Writing up outsourcing specific contracts and coming up with long term KPI’s to evaluate vendors you choose to work with
-What is the lifecycle of an outsourcing engagement? How does that evolve over time?

---

---

Clinical and non-clinical activities as they relate to R&D are by and large the biggest categories of indirect spend for biopharma. With so many investments being made in drug development, how can procurement better support innovation and drive efficiency? This session will look at how procurement can:

-Create value in an environment where speed, trust and quality are the key currencies
-Find opportunities to drive productivity across the organization to support the science
-Collaborate internally to simplify processes to cut down cycle time --Develop an innovation marketplace to simplify the search for suppliers
-Embed information on supplier and services to share knowledge globally
-Reduce cycle time in R&D, leading to significant cost reduction

---

---

---

---

Imagine it's the year 2020. Procurement has evolved so much over the past decade, you barely recognize it. Its functions have been decentralized – or outsourced! – leaving leadership to focus on very different things. Job descriptions have changed dramatically. What's more, suppliers seem to have infiltrated the organization. Today’s focus on cost savings will give way to a broader, more balanced emphasis on profitability, leaving open the question of whether supply management concentrates on cost savings or revenue growth to get there.

---

Richard Dean serves in Bristol-Myers Squibb’s Center of Excellence focused on global procurement market and risk intelligence analytics. His research supports an array of spend categories with actionable supplier capability assessments and performance scorecards that foster stronger relationships between Bristol-Myers Squibb and its worldwide supply base. Mr. Dean’s presentation will offer a case study view of the strategic nature of market and risk intelligence at BMS and how this function supports both better decision making and mutually beneficial customer-supplier outcomes.

---

Join your peers for the first of many networking breaks at ProcureCon Pharma. Chat over a coffee about what issues or concerns are top of mind for you in procurement and discuss what can be used to alleviate these.

Now that you’ve got the eyes and ears of internal business owners, how will you make the most of this opportunity? How can you work more closely to deliver the most value to the business? This panel discussion will explore:
After 40 minutes of panel discussion onstage, we will be taking the panel to the audience and will ask small groups in the audience to discuss the panel topics- giving you a chance to be a bit more interactive!

---

---

---

---

Led by each facilitator from the morning working groups. They will share key learnings with the whole audience.

Take a break, have a cup of coffee and explore the Networking Lounge. This is your home base for refreshments, snacks and chance to check out the latest technology and solutions to streamline your procurement processes and deliver maximum value to your organization.

In 2015 a top 10 biopharmaceutical company implemented the technology platform Science Exchange to improve performance in the category of outsourced scientific services. The biopharma company has consolidated its preclinical and discovery research outsourcing tail-spend ($10 million, 100 suppliers) into one strategic supplier relationship. This drove significant direct (10% ) and indirect cost savings and improved scientific productivity and access to innovation.

---

M&A activity and shifts in the global economy are pushing procurement to be more nimble and agile than ever before. Regardless of the maturity of your procurement department, or the size of your organization, the need to swiftly and smartly react to major business changes is paramount. Join this panel to learn more about: -Having a plan in place to address M&A before it happens -Gaining transparency of the supply chain you’re inheriting and its risks -Reviewing contracts and how they will affect spend in other divisions -Synergizing suppliers common to both companies -Engaging Employees to make sure they get what is happening and don’t feel out of the loop -Having frequent opportunities for the company to gather and discuss M&A pain points

---

---

---

After a busy day of interactive, solution-focused workshops, relax with fellow speakers and attendees.